Travere Therapeutics to Present at Upcoming Investor Conferences
Travere Therapeutics (NASDAQ: TVTX) has announced its participation in two major investor conferences in December 2024. The company will present at the 7th Annual Evercore HealthCONx Conference on Tuesday, December 3, at 10:00 a.m. ET, and the Citi 2024 Global Healthcare Conference on Wednesday, December 4, at 2:30 p.m. ET. Live webcasts will be available on Travere's investor relations website, with replays accessible for 30 days after each event.
Travere Therapeutics (NASDAQ: TVTX) ha annunciato la sua partecipazione a due importanti conferenze per investitori nel dicembre 2024. L'azienda presenterà alla 7ª Conferenza Annuale Evercore HealthCONx martedì 3 dicembre, alle 10:00 ET, e alla Conferenza Globale sulla Salute Citi 2024 mercoledì 4 dicembre, alle 14:30 ET. Saranno disponibili webcast in diretta sul sito web delle relazioni con gli investitori di Travere, con repliche accessibili per 30 giorni dopo ciascun evento.
Travere Therapeutics (NASDAQ: TVTX) ha anunciado su participación en dos importantes conferencias de inversores en diciembre de 2024. La compañía presentará en la 7ª Conferencia Anual Evercore HealthCONx el martes 3 de diciembre a las 10:00 a.m. ET, y en la Conferencia Global de Salud Citi 2024 el miércoles 4 de diciembre a las 2:30 p.m. ET. Se realizarán transmisiones en vivo en el sitio web de relaciones con inversores de Travere, con repeticiones accesibles durante 30 días después de cada evento.
Travere Therapeutics (NASDAQ: TVTX)는 2024년 12월에 열리는 두 개의 주요 투자자 회의에 참여한다고 발표했습니다. 회사는 12월 3일 화요일 오전 10시(ET)에 열리는 제7회 에버코어 HealthCONx 컨퍼런스와 12월 4일 수요일 오후 2시 30분(ET)에 열리는 시티 2024 글로벌 헬스케어 컨퍼런스에서 발표합니다. Travere의 투자자 관계 웹사이트에서 라이브 웹캐스트를 시청할 수 있으며, 각 이벤트 후 30일 동안 다시 볼 수 있습니다.
Travere Therapeutics (NASDAQ: TVTX) a annoncé sa participation à deux grandes conférences pour investisseurs en décembre 2024. L'entreprise présentera à la 7ème Conférence Annuelle Evercore HealthCONx le mardi 3 décembre à 10h00 ET, et à la Conférence Mondiale sur la Santé Citi 2024 le mercredi 4 décembre à 14h30 ET. Des webcasts en direct seront disponibles sur le site web des relations avec les investisseurs de Travere, avec des rediffusions accessibles pendant 30 jours après chaque événement.
Travere Therapeutics (NASDAQ: TVTX) hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im Dezember 2024 angekündigt. Das Unternehmen wird am Dienstag, den 3. Dezember, um 10:00 Uhr ET auf der 7. jährlichen Evercore HealthCONx-Konferenz vorstellen und am Mittwoch, den 4. Dezember, um 14:30 Uhr ET auf der Citi 2024 Global Healthcare Conference. Live-Webcasts werden auf der Investor-Relations-Website von Travere verfügbar sein, mit Wiederholungen, die 30 Tage nach jeder Veranstaltung zugänglich sind.
- None.
- None.
SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that company management will present in the following upcoming investor conferences in December:
7th Annual Evercore HealthCONx Conference
Tuesday, December 3, 2024, at 10:00 a.m. ET
Citi 2024 Global Healthcare Conference
Wednesday, December 4, 2024, at 2:30 p.m. ET
Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations, and replays will be available for up to 30 days following each event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
Contact:
| Investors: 888-969-7879 IR@travere.com | Media: 888-969-7879 mediarelations@travere.com |
FAQ
When is Travere Therapeutics (TVTX) presenting at the Evercore HealthCONx Conference in December 2024?
What time is Travere Therapeutics (TVTX) presenting at the Citi 2024 Global Healthcare Conference?
How long will the webcasts of Travere Therapeutics (TVTX) December 2024 conference presentations be available?
Where can I watch Travere Therapeutics (TVTX) December 2024 investor conference presentations?
